- $87.71m
- $91.53m
- $22.58m
- 47
- 31
- 23
- 25
C2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 21.1 | 19.5 | 20.2 | 21.4 | 22.6 |
Cost of Revenue | |||||
Gross Profit | 9.25 | 5.51 | 5.91 | 6.73 | 7.19 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 19.3 | 20.8 | 20.3 | 22.1 | 22.4 |
Operating Profit | 1.82 | -1.24 | -0.115 | -0.657 | 0.224 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 2.1 | -1.26 | 0.239 | -1 | -0.145 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.51 | -0.906 | 0.398 | -0.712 | -0.083 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.51 | -0.906 | 0.398 | -0.712 | -0.083 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.51 | -0.906 | 0.398 | -0.712 | -0.083 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.751 | -0.449 | -0.036 | -0.353 | -0.041 |